ReviewCurrent oncology reports2019

Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?

Sanjal Desai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.